TheAesthetic Index

Palomar StarLux (Lux1540/Lux2940)

Non-Ablative Fractional · Pulsed-light platform with fractional handpieces

Work at Palomar? — one claim covers all 6 of your devices.
Legacy-used-marketFDA status under verificationBe the first to review

New Palomar StarLux (Lux1540/Lux2940) pricing is not published; used and refurbished systems trade around $8k–$18k. Palomar StarLux (Lux1540/Lux2940)'s FDA status is under verification by our research team. Figures are market estimates verified August 6, 2026.

Last verified: August 6, 2026 · How we verify

New: —|Used: $8k–$18kmarket estimate, no email required

Key facts
ManufacturerPalomar
CompanyOwner: Hahn & Company (South Korean private equity) (private equity owned, since 2024) · Distribution: direct
CategoryResurfacing, Tattoo & Vascular
TechnologyPulsed-light platform with fractional handpieces
FDA statusFDA status under verification
New price rangeNot published
Used price range$8k–$18k
ConsumablesNot published
Launch year2006
Last verifiedAugust 6, 2026
Save device

Overview

Pre-Icon Palomar platform, cheap used

FDA & regulatory status

FDA status under verificationRegulatory status under verification

FDA status under verification — see our FDA guide. We do not publish an indication or a clearance number for this profile until the record is confirmed against the FDA database.

Regulatory data is compiled from public FDA 510(k) records and may lag recent clearances. Always confirm status with the manufacturer before purchase.

Recent industry events

How we source company data

Ownership and corporate changes at Palomar that can affect warranty, service and parts availability.

  1. Jan 2024

    Cynosure and Lutronic merge under Hahn & Company

    Merger

    Cynosure and Lutronic announced their merger on January 19, 2024, closing later that year to form Cynosure Lutronic, Inc. under South Korean private equity firm Hahn & Company; terms undisclosed. This followed CD&R's 2019 purchase of Cynosure from Hologic for $205M and Hahn's 2023 acquisition of Lutronic.

    Source: PR Newswire (Jan 19, 2024); Hologic filings

Treatment economics

Economics data for this platform hasn't been published yet.

Chains using this device

No confirmed chain deployments recorded yet.

Owner reviews

Write a review

No verified reviews yet — be the first. Founding reviewers get a thank-you gift card for an honest review, positive or negative. How verification works.

Alternatives

Solta (Reliant) Fraxel SR750

Non-Ablative Fractional

ProfileCompare

Solta Clear + Brilliant Touch

Non-Ablative Fractional · $50k–$70k

ProfileCompare

Lutronic LaseMD Ultra

Non-Ablative Fractional · $60k–$90k

ProfileCompare

Candela Frax Pro (Nordlys)

Non-Ablative Fractional

ProfileCompare

History

Every tracked change to pricing, lifecycle status, FDA data and warranty terms — newest first.

  1. August 1, 2026

    Record created

    Added to The Aesthetic Index — August 2026

    Source: The Aesthetic Index editorial

Get the full State of Aesthetic Devices 2026 report

The first full census of the US aesthetic device market — preview it free.

Get the report